Peak Bio Co., Ltd. To List On NASDAQ Following Successful Business Combination With Ignyte Acquisition Corp.
Peak Bio Co., Ltd. (“Peak Bio”), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory diseases, today announced the